June 7, 2022 Maccabi Healthcare Services announces it is the first HMO in the world to include MeMed BV® test as part of routine care View Article
June 3, 2022 Glatiramer Acetate Depot Shows Safety, Effectiveness in Progressive MS, Interim Results Suggest View Article
June 2, 2022 Gamida Cell Completes Rolling Biologics License Application Submission to the FDA for Omidubicel View Article
June 1, 2022 Gamida Cell Announces Opening to Enrollment of Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201 View Article
May 31, 2022 PolyPid Announces Completion of Enrollment in Phase 3 SHIELD I Trial of D-PLEX₁₀₀ for Prevention of Surgical Site Infections in Abdominal Surgery View Article
May 23, 2022 First Alpha DaRT Patients Treated in France as Part of Alpha DaRT™ Multicenter Skin Cancer Trial View Article
May 23, 2022 PolyPid Announces Recommendation by Data Safety Monitoring Board to Conclude Enrollment of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ at the Minimum Number of Patients Targeted Following Unblinded Interim Efficacy Analysis View Article
May 10, 2022 Apple Producer and Supplier Becomes Australia’s First Organic Company to Use Fully Home Compostable PackagingView Article
May 9, 2022 Yotpo Helps Brands Compete With Amazon, And It’s Hiring 400 People This Year View Article
April 29, 2022 CEO Spotlight: Lightricks CEO Zeev Farbman on the Evolution of the Creator Economy View Article
